SPI Infoamtion

1 Table Of Contents
1.1 List of Tables
1.2 List of Figures

2 Executive Summary

3 Global Glucose Monitoring Systems Market : Market Characterization
3.1 Overview
3.2 Glucose Monitoring Systems Market, Revenue ($ m), 2000 - 2008
3.3 Glucose Monitoring Systems Market, Revenue ($ m), 2008 - 2015
3.4 Glucose Monitoring Systems: Market Dynamics
3.4.1 Market Drivers
3.4.1.1 Increasing Prevalence of Diabetes to Boost Sales
3.4.1.2 Introduction of New Generation Devices to Drive the Glucose Monitoring Market
3.4.1.3 Home Healthcare to Boost Glucose Monitoring Market
3.4.1.4 Increasing Ageing and Obese Population Contributing to Diabetes Epidemic
3.4.1.5 Increasing Awareness about Diabetes, its Control and Related Complications to Drive the Market in Future
3.4.2 Market Restraints
3.4.2.1 High Cost and Reimbursement Hassles- a Growth Limiting Factor
3.4.2.2 Low Market Penetration Affecting Growth
3.4.2.3 Device Recalls Negatively Affect Physician and Patient Perceptions
3.5 Glucose Monitoring Systems: Perception Analysis
3.6 Glucose Monitoring Systems: Opportunities and Unmet Need
3.6.1 Major Unmet Needs
3.7 Key Takeaway

4 Global Glucose Monitoring Systems Market : Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Glucose Monitoring Systems Company Shares 2008
4.4 F. Hoffmann-La Roche Ltd
4.4.1 Diabetes Educational Programs by Roche
4.5 LifeScan (Johnson & Johnson)
4.5.1 Diabetes Educational Programs by Johnson & Johnson
4.6 Bayer Healthcare
4.6.1 Diabetes Educational Programs by Bayer Healthcare
4.7 Abbott Laboratories
4.7.1 Diabetes Educational programs by Abbott Labs
4.8 Product Profiles of the Major Marketed Products in the Glucose Monitoring Systems Market
4.8.1 Accu-Check Aviva
4.8.1.1 Overview
4.8.1.2 Efficacy
4.8.1.3 Safety Profile
4.8.1.4 Pricing
4.8.1.5 Clinical Trial Details
4.8.2 OneTouch Ultramini
4.8.2.1 Overview
4.8.2.2 Efficacy
4.8.2.3 Safety
4.8.2.4 Pricing
4.8.3 Contour Meter
4.8.3.1 Overview
4.8.3.2 Efficacy
4.8.3.3 Safety
4.8.3.4 Pricing
4.9 Key Takeaway

5 Global Glucose Monitoring Systems Market: Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Glucose Monitoring Systems - Pipeline by Clinical Phase of Development
5.4 Profiles of Promising Devices under Clinical Development
5.4.1 EyeSense Blood glucose measurement device
5.4.1.1 Overview
5.4.1.2 Efficacy
5.4.1.3 Safety
5.4.1.4 Clinical Study Detail
5.4.2 GlucoTrack
5.4.2.1 Overview
5.4.2.2 Efficacy
5.4.2.3 Safety
5.4.2.4 Clinical Study Details
5.4.3 LighTouch Monitor
5.4.3.1 Overview
5.4.3.2 Efficacy
5.4.3.3 Safety
5.5 Glucose Monitoring Systems Market: List of Pipeline Products
5.6 Glucose Monitoring Systems Pipeline Product Summary by Product Type
5.7 Glucose Monitoring Systems Pipeline Product Summary: Home Glucose Monitoring Systems
5.8 Glucose Monitoring Systems Pipeline Product Summary: Hospital Setting Glucose Monitoring Systems
5.9 Glucose Monitoring Systems Pipeline Product Summary: Both Home and Hospital Setting Glucose Monitoring Systems
5.10 Key Takeaway

6 Global Glucose Monitoring Systems Market : Implications for Future Market Competition
6.1 Strategic Competitor Assessment

7 Global Glucose Monitoring Systems Market: Emerging Companies
7.1 Introduction

8 Appendix
8.1 Definitions
8.1.1 Glucose Monitoring
8.1.1.1 Blood Glucose Meters
8.1.1.2 Blood Glucose Test Strips
8.2 Research Methodology
8.3 Secondary Research
8.4 Primary Research
8.5 Models
8.6 Forecasts
8.7 Expert Panels
8.8 GlobalData Consulting
8.9 Contact Us
8.10 Disclaimer

List of Figures
Figure 1: Glucose Monitoring Systems, Global, Revenue ($ m), 2000-2008
Figure 2: Glucose Monitoring Systems, Global, Revenue ($ m), 2008-2015
Figure 3: Diabetes Incidence by Diagnosis, US, 2007
Figure 4: Diabetic Population by Treatment Type, US, 2007
Figure 5: Glucose Monitoring Systems Perception Analysis
Figure 6: Glucose Monitoring Systems, Opportunity and Unmet Need
Figure 7: Strategic Competitive Assessment
Figure 8: Glucose Monitoring Systems, Company Shares - 2008
Figure 9: Technology Trends Analytic Framework
Figure 10: Technology Trends Analytic Framework - Descriptions
Figure 11: Glucose Monitoring Systems - Pipeline by Clinical Phase of Development
Figure 12: Glucose Monitoring Systems Pipeline Product by Product Type
Figure 13: Strategic Competitor Assessment
Figure 14: GlobalData Methodology

List of Tables
Table 1: Glucose Monitoring Systems, Global, Revenue ($ m), 2000-2008
Table 2: Glucose Monitoring Systems, Global, Revenue ($ m), 2008-2015
Table 3: Prevalence Estimates of Diabetes, Global, 2030
Table 4: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Age Group, US, 2007
Table 5: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Gender, US, 2007
Table 6: Glucose Monitoring Systems Pipeline Product Summary - I
Table 7: Glucose Monitoring Systems Pipeline Product Summary - II
Table 8: Glucose Monitoring Systems Pipeline Product Summary - III
Table 9: Home Glucose Monitoring Systems Pipeline Product Summary - I
Table 10: Home Glucose Monitoring Systems Pipeline Product Summary - II
Table 11: Hospital Setting Glucose Monitoring System Pipeline Product Summary
Table 12: Home and Hospital Setting Glucose Monitoring Systems Pipeline Product Summary
Table 13: Glucose Monitoring Systems Emerging Companies and Products- I
Table 14: Glucose Monitoring Systems Emerging Companies and Products - II